- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SNCA Antibody / Alpha-Synuclein Polyclonal Antibody targets alpha-synuclein, a small, intrinsically disordered protein encoded by the SNCA gene and involved in synaptic vesicle regulation, neurotransmitter release, and neuronal homeostasis. Alpha-synuclein belongs to the synuclein family alongside beta-synuclein and gamma-synuclein. Although concentrated at presynaptic terminals, it can also associate with other cellular membranes and participate in processes involving lipid organization and intracellular trafficking. Its ability to adopt different conformations depending on the surrounding environment is central to both its normal biological functions and its involvement in neurodegenerative disease.
Alpha-synuclein contains an amphipathic N-terminal region that interacts with lipid membranes, a hydrophobic central region known as the non-amyloid-beta component (NAC), and an acidic C-terminal region involved in protein interactions and conformational regulation. Membrane binding promotes the formation of alpha-helical structures, while unbound alpha-synuclein remains highly dynamic. The protein interacts with synaptic vesicle components and has been implicated in regulating vesicle clustering, recycling, and neurotransmitter release. Interactions with synaptobrevin-2, also known as VAMP2, suggest a role in organizing SNARE-associated processes involved in synaptic vesicle fusion.
Under pathological conditions, alpha-synuclein can misfold and assemble into soluble oligomers, protofibrils, and amyloid fibrils. Aggregated alpha-synuclein is a major component of Lewy bodies and Lewy neurites, characteristic pathological structures associated with Parkinson's disease and dementia with Lewy bodies. Abnormal alpha-synuclein accumulation is also implicated in multiple system atrophy. These disorders are collectively classified as synucleinopathies, although their affected cell populations and patterns of protein accumulation differ. Genetic alterations involving SNCA, including missense mutations and gene multiplications, further establish a connection between alpha-synuclein abundance, aggregation, and neurodegeneration.
Alpha-synuclein undergoes several post-translational modifications, including phosphorylation, ubiquitination, nitration, and N-terminal acetylation. Phosphorylation at Ser129 is particularly enriched in pathological aggregates, although its precise contribution to aggregation and toxicity remains an active area of investigation. Misfolded alpha-synuclein can disrupt mitochondrial function, protein clearance pathways, and intracellular membrane trafficking. Evidence also supports the ability of certain aggregated species to promote templated misfolding and propagation between cells. Understanding how these processes interact with normal synaptic functions remains important for defining mechanisms of neuronal vulnerability. The SNCA Antibody provides a means of investigating alpha-synuclein expression in relation to synaptic regulation, protein homeostasis, and neurodegenerative disease mechanisms.
Explore our Neuroscience Antibodies collection for additional research antibodies targeting proteins involved in synaptic signaling, neuronal function, protein aggregation, and neurodegenerative disease mechanisms.
Optimal dilution of the SNCA Antibody / Alpha-Synuclein Polyclonal Antibody should be determined by the researcher.
E.coli-derived human Alpha Synuclein/SNCA recombinant protein (Position: M1-D135) was used as the immunogen for the SNCA antibody.
After reconstitution, the SNCA antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Alpha synuclein antibody, Alpha-synuclein protein antibody, Synuclein alpha antibody, Alpha synuclein 140 antibody, Non-amyloid beta component precursor antibody, NACP antibody, Parkinson disease protein 1 antibody, Synuclein family alpha protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.